Stay updated on Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Sign up to get notified when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Padua, Italy, 35128 was replaced with Padova, Italy, 35128 in the locations section.
    Difference
    0.0%
    Check dated 2026-04-09T08:38:01.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The Napoli, Italy, 80131 site listing was changed to Naples, Italy, 80131. The city name now uses the English form.
    Difference
    0.0%
    Check dated 2026-03-25T21:23:40.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2026-03-18T17:52:50.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T14:58:58.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; deleted the notices for Revision: v3.4.1 and the government funding lapse notice.
    Difference
    0.3%
    Check dated 2026-02-11T01:50:08.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Site-wide notice added about a lapse in government funding and NIH Clinical Center operations; Revision: v3.4.1 replaces v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-03T23:18:01.000Z thumbnail image

Stay in the know with updates to Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.